To begin with, Sheer said to be honest about the outcome. “Tell the patient ‘Maybe’ and ‘We will try.’ Have a plan A and plan ...
GLP-1 drugs like Ozempic and Wegovy are transforming public health and consumer habits. Here we explore their explosive ...
When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...
GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis ...
Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...
Come prepared with the right questions and information about your goals, weight loss history, and diet and exercise plan to ...
Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...
Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...
There's mounting evidence that popular drugs prescribed for diabetes management and weight loss—better known by trade names ...
GLP-1–pathway agonists such as semaglutide and newer multi-agonists have transformed care for obesity and diabetes, yet developers still wrestle with durability, tissue targeting, and signal "bias." ...
A Virginia Tech study suggests GLP-1 drugs like Ozempic and Wegovy slow alcohol absorption and reduce its effects on the ...